Operating Expenses Summary of AnteoTech Limited

AnteoTech Limited's latest annual operating expenses in 2024 was 12.18 Million AUD , down -4.18% from previous year.
AnteoTech Limited's latest quarterly operating expenses in 2024 FY was 12.14 Million AUD , down -4.52% from previous quarter.
AnteoTech Limited reported a annual operating expenses of 12.71 Million AUD in annual operating expenses 2023, down -1.27% from previous year.
AnteoTech Limited reported a annual operating expenses of 12.88 Million AUD in annual operating expenses 2022, up 57.16% from previous year.
AnteoTech Limited reported a quarterly operating expenses of 12.14 Million AUD for 2024 FY, down -4.52% from previous quarter.
AnteoTech Limited reported a quarterly operating expenses of 6.02 Million AUD for 2024 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of AnteoTech Limited (2024 - 1999)

Historical Annual Operating Expenses of AnteoTech Limited (2024 - 1999)

Year	Operating Expenses	Operating Expenses Growth
2024	12.18 Million AUD	-4.18%
2023	12.71 Million AUD	-1.27%
2022	12.88 Million AUD	57.16%
2021	8.19 Million AUD	106.17%
2020	3.97 Million AUD	10.91%
2019	3.58 Million AUD	-6.14%
2018	3.81 Million AUD	-52.85%
2017	8.09 Million AUD	-8.23%
2016	8.82 Million AUD	81.71%
2015	4.85 Million AUD	63.13%
2014	2.97 Million AUD	-28.2%
2013	4.14 Million AUD	3.8%
2012	3.99 Million AUD	20.17%
2011	3.32 Million AUD	14.7%
2010	2.89 Million AUD	1.56%
2009	2.85 Million AUD	-8.81%
2008	3.12 Million AUD	-7.85%
2007	3.39 Million AUD	-13.72%
2006	3.93 Million AUD	64.86%
2005	2.38 Million AUD	-50.62%
2004	4.83 Million AUD	-5.95%
2003	5.14 Million AUD	-16.22%
2002	6.13 Million AUD	540.56%
2001	-1.39 Million AUD	-27.43%
2000	-1.09 Million AUD	-26906.87%
1999	4078.00 AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q4	6.16 Million AUD	0.0%
2024 FY	12.14 Million AUD	-4.52%
2024 Q2	6.02 Million AUD	0.0%
2023 Q2	6.65 Million AUD	0.0%
2023 FY	12.71 Million AUD	-1.27%
2023 Q4	6.05 Million AUD	0.0%
2022 FY	12.88 Million AUD	57.16%
2022 Q4	6.99 Million AUD	0.0%
2022 Q2	5.88 Million AUD	0.0%
2021 FY	8.19 Million AUD	106.17%
2021 Q2	3.1 Million AUD	0.0%
2021 Q4	5.08 Million AUD	0.0%
2020 Q4	2 Million AUD	0.0%
2020 FY	3.97 Million AUD	10.91%
2020 Q2	1.96 Million AUD	0.0%
2019 FY	3.58 Million AUD	-6.14%
2019 Q2	1.82 Million AUD	0.0%
2019 Q4	1.76 Million AUD	0.0%
2018 Q4	- AUD	0.0%
2018 Q2	2.38 Million AUD	0.0%
2018 FY	3.81 Million AUD	-52.85%
2017 Q4	- AUD	0.0%
2017 FY	8.09 Million AUD	-8.23%
2017 Q2	6.67 Million AUD	0.0%
2016 Q4	- AUD	0.0%
2016 Q2	3.62 Million AUD	0.0%
2016 FY	8.82 Million AUD	81.71%
2015 FY	4.85 Million AUD	63.13%
2015 Q4	2.5 Million AUD	0.0%
2015 Q2	2.34 Million AUD	0.0%
2014 Q2	673.13 Thousand AUD	0.0%
2014 Q4	2.3 Million AUD	0.0%
2014 FY	2.97 Million AUD	-28.2%
2013 Q2	836.36 Thousand AUD	-13.92%
2013 Q1	971.64 Thousand AUD	0.0%
2013 FY	4.14 Million AUD	3.8%
2013 Q4	1.73 Million AUD	72.09%
2013 Q3	1 Million AUD	20.22%
2012 Q4	- AUD	-100.0%
2012 Q2	971.64 Thousand AUD	15446.29%
2012 Q1	6250.00 AUD	0.0%
2012 FY	3.99 Million AUD	20.17%
2012 Q3	971.64 Thousand AUD	0.0%
2011 Q3	6250.00 AUD	0.0%
2011 FY	3.32 Million AUD	14.7%
2011 Q2	6250.00 AUD	-58.39%
2011 Q1	15.01 Thousand AUD	0.0%
2011 Q4	- AUD	-100.0%
2010 Q2	15.01 Thousand AUD	-26.01%
2010 Q3	15.01 Thousand AUD	0.0%
2010 FY	2.89 Million AUD	1.56%
2010 Q4	- AUD	-100.0%
2010 Q1	20.29 Thousand AUD	0.0%
2009 Q2	20.29 Thousand AUD	152.97%
2009 Q3	20.29 Thousand AUD	0.0%
2009 Q4	- AUD	-100.0%
2009 Q1	8023.75 AUD	0.0%
2009 FY	2.85 Million AUD	-8.81%
2008 Q3	8023.75 AUD	0.0%
2008 Q1	793.00 AUD	0.0%
2008 FY	3.12 Million AUD	-7.85%
2008 Q4	- AUD	-100.0%
2008 Q2	8023.75 AUD	911.82%
2007 FY	3.39 Million AUD	-13.72%
2007 Q4	- AUD	-100.0%
2007 Q2	793.00 AUD	-98.66%
2007 Q1	59.32 Thousand AUD	0.0%
2007 Q3	793.00 AUD	0.0%
2006 FY	3.93 Million AUD	64.86%
2006 Q2	59.32 Thousand AUD	-13.85%
2006 Q3	59.32 Thousand AUD	0.0%
2006 Q1	68.86 Thousand AUD	0.0%
2006 Q4	- AUD	-100.0%
2005 Q3	68.86 Thousand AUD	0.0%
2005 Q1	117.15 Thousand AUD	0.0%
2005 Q4	- AUD	-100.0%
2005 Q2	68.86 Thousand AUD	-41.22%
2005 FY	2.38 Million AUD	-50.62%
2004 Q3	117.15 Thousand AUD	0.0%
2004 Q4	- AUD	-100.0%
2004 FY	4.83 Million AUD	-5.95%
2004 Q1	105.9 Thousand AUD	0.0%
2004 Q2	117.15 Thousand AUD	10.63%
2003 Q4	- AUD	-100.0%
2003 Q1	152.25 Thousand AUD	0.0%
2003 Q3	105.9 Thousand AUD	0.0%
2003 Q2	105.9 Thousand AUD	-30.44%
2003 FY	5.14 Million AUD	-16.22%
2002 Q1	-698.57 Thousand AUD	0.0%
2002 Q2	152.25 Thousand AUD	121.79%
2002 FY	6.13 Million AUD	540.56%
2002 Q3	152.25 Thousand AUD	0.0%
2002 Q4	- AUD	-100.0%
2001 Q2	-698.57 Thousand AUD	-155.61%
2001 FY	-1.39 Million AUD	-27.43%
2001 Q4	- AUD	100.0%
2001 Q3	-698.57 Thousand AUD	0.0%
2001 Q1	-273.29 Thousand AUD	0.0%
2000 Q1	1019.50 AUD	0.0%
2000 Q2	-273.29 Thousand AUD	-26906.87%
2000 Q3	-273.29 Thousand AUD	0.0%
2000 Q4	-273.29 Thousand AUD	0.0%
2000 FY	-1.09 Million AUD	-26906.87%
1999 Q3	1019.50 AUD	0.0%
1999 FY	4078.00 AUD	0.0%
1999 Q4	1019.50 AUD	0.0%
1999 Q2	1019.50 AUD	0.0%

Peer Operating Expenses Comparison of AnteoTech Limited

Name	Operating Expenses	Operating Expenses Difference
AdAlta Limited	6.76 Million AUD	-80.028%
Biome Australia Limited	7.91 Million AUD	-54.047%
Radiopharm Theranostics Limited	299.22 Thousand AUD	-3972.814%
Biotron Limited	5.11 Million AUD	-138.462%
Acrux Limited	8.55 Million AUD	-42.538%
Alterity Therapeutics Limited	23.4 Million AUD	47.934%
Botanix Pharmaceuticals Limited	601.82 Thousand AUD	-1925.024%
BTC Health Limited	-1.03 Million AUD	1273.037%
Chimeric Therapeutics Limited	19.76 Million AUD	38.348%
CSL Limited	7.56 Billion AUD	99.839%
Clarity Pharmaceuticals Ltd	56.3 Million AUD	78.356%
Clinuvel Pharmaceuticals Limited	31.29 Million AUD	61.06%
Immutep Limited	42.87 Million AUD	71.576%
Memphasys Limited	3.67 Million AUD	-231.314%
Neuren Pharmaceuticals Limited	32.69 Million AUD	62.727%
Noxopharm Limited	7 Million AUD	-74.095%
Prescient Therapeutics Limited	10.89 Million AUD	-11.82%
Race Oncology Limited	14.77 Million AUD	17.491%
Starpharma Holdings Limited	22.81 Million AUD	46.586%
Tissue Repair Ltd	6.66 Million AUD	-82.801%
EZZ Life Science Holdings Limited	39.57 Million AUD	69.205%
Anatara Lifesciences Ltd	710.21 Thousand AUD	-1615.955%
Bio-Gene Technology Limited	2.76 Million AUD	-341.396%
Zelira Therapeutics Limited	5.94 Million AUD	-104.875%
Patrys Limited	4.93 Million AUD	-147.035%
Orthocell Limited	15.36 Million AUD	20.707%
Imugene Limited	135.09 Million AUD	90.979%
PYC Therapeutics Limited	60.91 Million AUD	79.994%
Proteomics International Laboratories Limited	892.14 Thousand AUD	-1266.037%
Cynata Therapeutics Limited	11.12 Million AUD	-9.56%
Arovella Therapeutics Limited	10.78 Million AUD	-12.997%
Nanollose Limited	12.5 Thousand AUD	-97388.209%
Invex Therapeutics Ltd	3.34 Million AUD	-264.239%
NeuroScientific Biopharmaceuticals Limited	1.96 Million AUD	-520.134%
Amplia Therapeutics Limited	8.43 Million AUD	-44.469%
Island Pharmaceuticals Limited	4.12 Million AUD	-195.417%
Nyrada Inc.	4.55 Million AUD	-167.542%
Telix Pharmaceuticals Limited	269.26 Million AUD	95.474%
Dimerix Limited	25.64 Million AUD	52.475%
PharmAust Limited	6.65 Million AUD	-83.071%
Hexima Limited	1 Million AUD	-1108.129%
Paradigm Biopharmaceuticals Limited	65.1 Million AUD	81.28%
Recce Pharmaceuticals Ltd	21.68 Million AUD	43.798%
Avecho Biotechnology Limited	4.54 Million AUD	-168.118%
Actinogen Medical Limited	22.77 Million AUD	46.479%
Immuron Limited	9.13 Million AUD	-33.367%
Argenica Therapeutics Limited	8.26 Million AUD	-47.379%

Global Stocks Search

AnteoTech Limited (ADO.AX)

Operating Expenses Summary of AnteoTech Limited

Annual Operating Expenses Chart of AnteoTech Limited (2024 - 1999)

Historical Annual Operating Expenses of AnteoTech Limited (2024 - 1999)

Peer Operating Expenses Comparison of AnteoTech Limited